FDA official logo
GSRS logo
PFDA official logo

2'3'-CYCLIC GUANOSINE MONOPHOSPHATE-ADENOSINE MONOPHOSPHATE

  • UNII: 552Y49K43E
  • Formula: C20H24N10O13P2
  • Preferred Substance Name: 2'3'-CYCLIC GUANOSINE MONOPHOSPHATE-ADENOSINE MONOPHOSPHATE
  • InChIKey: XRILCFTWUCUKJR-INFSMZHSSA-N

  • 1441190-66-4
  • 1SY
  • 2'3'-CGAMP
  • 2-AMINO-9-((1R,6R,8R,9R,10S,15R,17R,18R)-8-(6-AMINO-9H-PURIN-9-YL)-3,9,12,18-TETRAHYDROXY-3,12-DIOXIDO-2,4,7,11,13,16-HEXAOXA-3,12-DIPHOSPHATRICYCLO(13.2.1.06,10)OCTADEC-17-YL)-1,9-DIHYDRO-6H-PURIN-6-ONE
  • 2-AMINO-9-((2R,5R,7R,8R,10S,12AR,14R,15R,15AS,16R)-14-(6-AMINO-9H-PURIN-9-YL)-2,10,15,16-TETRAHYDROXY-2,10-DIOXIDOOCTAHYDRO-12H-5,8-METHANOFURO(3,2-L)(1,3,6,9,11,2,10)PENTAOXADIPHOSPHACYCLOTETRADECIN-7-YL)-3,9-DIHYDRO-6H-PURIN-6-ONE
  • 2-AMINO-9-((5R,7R,8R,12AR,14R,15R,15AS,16R)-14-(6-AMINO-9H-PURIN-9-YL)-2,10,15,16-TETRAHYDROXY-2,10-DIOXIDOOCTAHYDRO-12H-5,8-METHANOFURO(3,2-L)(1,3,6,9,11,2,10)PENTAOXADIPHOSPHACYCLOTETRADECIN-7-YL)-1,9-DIHYDRO-6H-PURIN-6-ONE
  • 2'-GUANYLIC ACID, ADENYLYL-(3'->5')-, CYCLIC NUCLEOTIDE
  • 2'-O,5'-O-((ADENOSINE-3'-O,5'-O-DIYL)BISPHOSPHINICO)GUANOSINE
  • 5'-O,2'-O-(3',5'-DIDEOXYADENOSINE-3',5'-DIYLBIS(OXY(HYDROXYPHOSPHINYLIDENE)))GUANOSINE
  • 6H-PURIN-6-ONE, 2-AMINO-9-((5R,7R,8R,12AR,14R,15R,15AS,16R)-14-(6-AMINO-9H-PURIN-9-YL)OCTAHYDRO-2,10,15,16-TETRAHYDROXY-2,10-DIOXIDO-5,8-METHANO-12H-FURO(3,2-L)-1,3,6,9,11,2,10-PENTAOXADIPHOSPHACYCLOT ETRADECIN-7-YL)-1,9-DIHYDRO-
  • C(G(2',5')PA(3',5')P)
  • C20640
  • CGAMP
  • CGAMP(2'-5')
  • CYCLIC GMP-AMP
  • CYCLIC GP(2'-5')AP(3'-5')
  • CYCLIC GUANOSINE MONOPHOSPHATE-ADENOSINE MONOPHOSPHATE
  • J3.180.146J

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.